Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1556 of 6351
-
AI chatbot aims to tackle America's sleep crisis
Symptom relief Recruiting nowSleep is a major public health concern in the United States. Major guidelines recommend that adults obtain at least 7 hours of sleep per night. More than 25% of U.S. adults do not meet this recommendation, and 14.5% report difficulty falling asleep on most days or every day durin…
Sponsor: New York University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New brain monitoring tech could predict strokes during heart surgery
Knowledge-focused Not yet recruitingPostoperative stroke following cardiac surgery is associated with a ninefold increase in mortality risk compared to patients without stroke. Perioperative monitoring in cardiac surgery involves a range of complex and diverse techniques, presenting significant challenges for anest…
Sponsor: Beijing Tiantan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
AI could take the guesswork out of sperm selection for IVF
Diagnosis Not yet recruitingInfertility is defined as a failure of a couple to achieve a pregnancy after 12 or more months of unprotected intercourse. Males are found to be solely responsible for 20-30% of infertility cases but contribute to 50% of cases overall. The selection of sperm to microinject is com…
Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA • Aim: Diagnosis
Last updated Jun 26, 2026 14:46 UTC
-
New antibody treatment could tame rare brain disease Flare-Ups
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of different monoclonal antibody in the acute phase of neuromyelitis optica spectrum disorder (MAAP-NMO). It will also examine immune-related biomarkers and their relationship with treatment response to provide evidence for opti…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 26, 2026 19:21 UTC
-
Earlier skull patch may boost brain healing
Disease control Not yet recruitingTo compare the neurological recovery and complication rate of autogenous cranioplasty(CP) within 6 weeks after decompressive craniectomy (DC) with that of autogenous cranioplasty within 3\~6 months after DC.
Sponsor: The Affiliated Hospital Of Guizhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 19:15 UTC
-
Simple breathing workout may free ventilator patients faster
Disease control Not yet recruitingProlonged mechanical ventilation (PMV) and weaning failure can lead to extended hospital stays, as well as increased morbidity and mortality during hospitalization. Therefore, PMV not only increases the economic burden on patients and their families, but also adds to the societal…
Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Laser zaps brain tumor, then chemo moves in: new combo trial opens
Disease control Recruiting nowThis is a phase 1 study evaluating the safety and feasibility of laser interstitial thermal therapy (LITT) followed by lomustine (CCNU) for recurrent glioblastoma in adults. The primary aim is to evaluate the safety of the combination of LITT plus lomustine based on the assessmen…
Phase 1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Brain zaps and scans: new hope for alcohol addiction?
Disease control Recruiting nowThe goal of this clinical study is to test the effectiveness of a supplemental fMRI neurofeedback and/or TMS intervention in individuals seeking treatment for Alcohol Use Disorder. After an initial visit, participants will come in once a week for four (4) weeks for an interventi…
Sponsor: Auburn University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
AI could help doctors spot thyroid problems faster and more accurately
Diagnosis OngoingThe goal of this observational study is to evaluate the diagnostic accuracy and clinical workflow integration of an ultrasound intelligent agent (UIA) for thyroid disease management in a real-world multicenter setting. The primary research question is: Can the UIA improve diagno…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
New pill hopes to tame ulcerative colitis in older adults
Disease control Recruiting nowEligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod ad…
Sponsor: Showa Inan General Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Papaya leaf extract tested as dengue treatment for kids
Disease control By invitation onlyThe goal of this clinical trial is to evaluate whether Carica papaya leaf extract (CPLE) can improve platelet counts in children aged 2 to 12 years diagnosed with dengue fever and thrombocytopenia. The main questions it aims to answer are: Does Carica papaya leaf extract signifi…
Phase 2 • Sponsor: Ziauddin Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:24 UTC
-
New pill may shrink lung tumors before surgery in Gene-Mutated cancers
Disease control Not yet recruitingThis is a prospective, single-center phase II clinical study aimed at evaluating the efficacy and safety of Vebreltinib in neoadjuvant treatment for patients with resectable stage IIA-IIIB (N2) non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutations. In the study, …
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 26, 2026 13:55 UTC
-
New drug mimics IVIg to fight low platelet disorder
Disease control Recruiting nowThe purpose of the study is to evaluate the safety of NVG-2089 and to evaluate how well patients respond to this investigational treatment. NVG-2089 is a new drug that is being developed for treating patients with ITP. NVG-2089 is designed to mimic the effects of a protein called…
Phase 2 • Sponsor: Nuvig Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study tests apremilast for psoriasis relief
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of Apremilast tablets in patients with psoriasis over 32 weeks, through a multicenter, single-arm, open-label, phase 4 clinical trial.
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for severe colitis: experimental drug BRS201 enters human trial
Disease control Recruiting nowThis study is a clinical trial being done to investigate the efficacy of drug BRS201 as a treatment in patients with acute ulcerative colitis. Patients who qualify are adults who have not responded to treatments for their severe ulcerative colitis. Participation in this study wil…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for rare cancer: targeted pill tested in advanced sarcoma
Disease control Recruiting nowThis is a prospective, cohort, multicenter study. Cohort 1 is treatment group. All eligible subjects will receive Vebreltinib (200 mg bid po) after signing the informed consent and meeting the inclusion/exclusion criteria, until disease progression, intolerable toxicity, or death…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Sound waves may unlock secrets of Treatment-Resistant depression
Knowledge-focused Recruiting nowApproximately one third of individuals with Major Depressive Disorder (MDD) are considered treatment-resistant, subject to severe disability and risk of suicide, and exhibit symptoms anchored in abnormalities of Research Domain Criteria (RDoC) Negative Valence Systems behavioral …
Sponsor: Laureate Institute for Brain Research, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Can unresponsive patients still form memories? new study investigates
Knowledge-focused Recruiting nowFollowing severe brain damage, some individuals lose partial or total awareness of themselves and their environment, falling into a coma that can evolve towards a Disorder of Consciousness (DoC). Accurately diagnosing the depth of consciousness alteration, and thus characterizing…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can your own blood help regrow hair? new trial tests PRP for scarring hair loss
Disease control Not yet recruitingThis study aims to investigate whether platelet-rich plasma (PRP) injections can help treat central centrifugal cicatricial alopecia (CCCA), a type of scarring hair loss that mostly affects women of African descent. CCCA is a condition that leads to permanent hair loss, usually s…
Phase 4 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New cholesterol drug tested right after heart attack to stop second one
Disease control Recruiting nowEvaluation of clinical outcomes during 12 months after inclisiran initiation in patients after STEMI/non-STEMI in real-world settings in Russia. It is also planned to study the therapy effect on the lipid profile characteristics, its safety, the state of atherosclerotic plaques a…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC